Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xolair Add-on in Severe Persistent Allergic Asthma
NCT00567476Phase 4Completed
- Sponsor
- Novartis
- Start
- Nov 2007
- Primary completion
- Apr 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of omalizumab in allergic asthma, sponsored by Novartis. Started Nov 2007; status: completed.
02
Drugs
omalizumab
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT00567476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00567476.